AC IMMUNE SA SF-02 (IMR) — Working Capital to Net Assets Ratio

AC IMMUNE SA SF-02 (IMR) has a Working Capital to Net Assets ratio of -19.4% as of June 2026. Working capital of €-6.84 Million (current assets of €93.40 Million minus current liabilities of €100.24 Million) is measured against net assets of €35.17 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See how many days can AC IMMUNE SA SF-02 fund operations to measure how many days the company can operate on defensive assets alone.